Breadcrumbs Home Media Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2022-03-28 08:00European marketing authorization application for MOB-015 submittedRead more 2022-03-25 08:00The last day for trading in Moberg Pharma's warrants of series 2020:1 is today, 25 March 2022Read more 2022-03-18 08:00Moberg Pharma announces regulatory submission to FDA for North American phase 3 studyRead more 2022-03-16 08:00The exercise period for Moberg Pharma's warrants of series 2020:1 begins todayRead more 2022-03-14 08:00Subscription price for Moberg Pharma's warrants of series 2020:1 determinedRead more 2022-02-08 08:00Moberg Pharmas Year-end report 2021Read more Pagination First page Previous page … Page 13 Page 14 Page 15 Page 16 Current page 17 Page 18 Page 19 Page 20 Page 21 … Next page Last page Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2021-02-02 08:00Moberg Pharma's Year-end report for the financial year 2020 to be published on February 9 - Invitation to teleconferenceRead more 2020-12-23 15:00Moberg Pharma's rights issue of MSEK 150 is fully subscribed and no issue guarantees have been usedRead more 2020-12-03 12:30Moberg Pharma publishes prospectus relating to the rights issueRead more 2020-12-01 13:30Bulletin from Moberg Pharma's Extraordinary General Meeting on December 1[st], 2020Read more 2020-11-30 08:00New number of shares and votes in Moberg Pharma AB (publ)Read more 2020-11-27 08:00Moberg Pharma announces the final terms of the fully guaranteed rights issueRead more Pagination First page Previous page … Page 13 Page 14 Page 15 Page 16 Current page 17 Page 18 Page 19 Page 20 Page 21 … Next page Last page
